Drawing for KARVEA

USPTO serial 74726343

KARVEA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
POWERS, ALEXANDER L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KARVEA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark I. Peroff

MARK I PEROFF TRADEMARK COUNSELORS OF AMERICA PC915 BROADWAYNEW YORK, NY 10010UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical products for the prevention and treatment of cardiovascular troublesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 1998ABN1ABANDONMENT - EXPRESS MAILED—
May 21, 1998DOCKASSIGNED TO EXAMINER—
Apr 9, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 1998DOCKASSIGNED TO EXAMINER—
Oct 17, 1996CNSLLETTER OF SUSPENSION MAILED—
Sep 3, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 20, 1996UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Apr 29, 1996CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 19961.BDSec. 1(B) CLAIM DELETED—
Mar 1, 1996CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 1996DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance